Lv2
125 积分 2022-06-18 加入
Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial
4天前
已完结
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
10天前
已完结
Breast Cancer Metastases in Liver: Laser-induced Interstitial Thermotherapy—Local Tumor Control Rate and Survival Data
8个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
8个月前
已完结
Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival
8个月前
已关闭
Ribociclib plus Endocrine Therapy in Early Breast Cancer
9个月前
已完结
Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor Cancer Therapy Strategy in Breast Cancer Patients
9个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
10个月前
已完结
A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
11个月前
已完结
Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy
11个月前
已完结
皖公网安备34019202002308
